Highlights Inhibition of hepatic microRNA-34a (miR-34a) and it's expression may help reduce liver injury and liver fibrosis in ALD patients Chronic alcohol consumption can cause abnormal fat accumulation in liver cells (steatosis) and liver fibrosis, which can lead to hepatitis, cirrhosis, and sometimes liver cancer Up-regulation of miR-34a during alcohol consumption contributes to the development of liver fibrosis during alcoholic liver injury Targeting the drivers of aging and senescent cells may be a novel therapeutic strategy to reduce hepatic steatosis and liver fibrosis in ALD patients Cellular aging and its activating factor such as microRNA-34a can trigger excessive liver fibrosis in Alcoholic Liver Disease (ALD) patients found a new study published in The American Journal of Pathology. According to The National Institute on Alcohol Abuse and Alcoholism in 2015, nearly half of 80,000 deaths due to liver diseases were related to alcoholic liver disease (ALD) "We believe that senescent cells contribute to age-related tissue degeneration during chronic liver injuries," explained co-author Fanyin Meng, MD, PhD, Associate Professor of Internal Medicine at Baylor Scott & White Digestive Disease Research Center (BSWDDRC), Texas A&M College of Medicine and Central Texas Veterans Health Care System, Temple, TX. New Targets Identified to Minimize Alcoholic Liver Disease’s Ill Effects "Cellular senescence refers to a state of irreversible cell-cycle arrest combined with the secretion of proinflammatory cytokines and hepatocellular dysfunction. Our study demonstrates that the drivers of aging are critical mediators of ALDs." ‘In 2015, nearly half of 80,000 deaths due to liver diseases in the United States were related to alcoholic liver disease (ALD), according to the National Institute on Alcohol Abuse and Alcoholism.’ Investigators studied liver tissue from patients with steatohepatitis, who were heavy alcohol drinkers, and from ethanol-fed mice to identify biochemical markers of cellular senescence. Their findings indicate that up-regulation of microRNA-34a (miR-34a) during alcohol consumption contributes to the development of liver fibrosis during alcoholic liver injury. The fibrosis-producing effects of miR-34a are related to different aging signaling in two different liver cell types. Particularly, in hepatocytes, the primary liver cells that make up 70% to 85% of the liver's mass and perform the basic functions of the liver, senescence is increased. On the contrary, senescence is decreased in activated hepatic stellate cells (HSCs), the supportive cells which, when triggered by alcohol or other liver insults, begin to produce excessive fibrotic material. Their research also shows that inhibition of hepatic miR-34a expression reduces liver injury and liver fibrosis in ALD. "Understanding the mechanisms underlying HSC activation and regression has become an increased area of interest, and our findings help to advance understanding of the complex nature of this phenomenon," noted Dr. Meng. On a broader scale, the study identifies a novel pathway by which HSC activation and regression are regulated, which could potentially be applied to other aging-associated fibrotic liver diseases. "Targeting the drivers of aging and senescent cells may be a novel therapeutic strategy to reduce hepatic steatosis and liver fibrosis in ALD patients," commented co-author Gianfranco Alpini, PhD, Distinguished Professor in the Department of Medical Physiology at Texas A&M College of Medicine, Senior Research Scientist at Central Texas Veterans Health Care System, and Director of the BSW DDRC. Further, co-author Heather Francis, Ph.D., Associate Professor of Medical Physiology at Texas A&M College of Medicine and member of the BSWDDRC, stated, "It is imperative to identify regulatory targets for potential treatment of ALDs, especially for populations that are greatly impacted by this disease". Moreover, Shannon Glaser, Ph.D., Associate Professor of Medical Physiology at Texas A&M College of Medicine and member of the BSWDDRC added, "Targeting the miR-34a may also be key for managing liver fibrosis in other cholangiopathies such as primary sclerosing cholangitis as well as primary biliary cholangitis. Our study opens the window for the possibility of linking age-related genes as therapeutics for the future." Reference Ying Wan, Kelly McDaniel, Nan Wu, Sugeily Ramos-Lorenzo, Trenton Glaser, Julie Venter, Heather Francis, Lindsey Kennedy, Keisaku Sato, Tianhao Zhou, Konstantina Kyritsi, Qiaobing Huang, Tami Annable, Chaodong Wu, Shannon Glaser, Gianfranco Alpini, Fanyin Meng. Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury. The American Journal of Pathology, 2017. DOI: 10.1016/j.ajpath.2017.08.027 Source: Eurekalert << Inner Ear Stem Cells may Restore Hearing in Future Old Cells can Now be Rejuvenated to Slow Down Aging >> Recommended Reading Alcoholic Liver Disease Encyclopedia section of medindia gives general information about Alcoholic Liver Disease. READ MORE Patients at Risk of Developing Alcoholic Liver Disease Identified Many people who die from alcoholic liver disease have a history of alcohol misuse and recurrent hospital admissions. READ MORE Liver Protein Could Be Used To Treat Alcohol Liver Disease A protein called fibroblast growth factor 21 (FGF21) helps protect mice against diet-related toxicities to the liver. READ MORE New Hope for Treating Non-Alcoholic Fatty Liver Disease Researchers have discovered a new pathway in the liver that opens the door to treat non-alcoholic fatty liver disease. READ MORE Current Treatments for Liver Cancer Current Treatments for Liver Cancer (also known as hepatoma or hepatocellular carcinoma) can result in complete cure of the disease if it is detected early. READ MORE Fatty Liver Disease: A Growing Health Problem in India Non alcoholic fatty liver disease (NAFLD) is the leading cause of liver dysfunction worldwide and is a rapidly growing health problem in India. READ MORE Hepatitis A Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. Hepatitis A vaccine is available that is 95% effective in preventing the disease. READ MORE Living Donor Liver Transplant: What Are the Risks? The risk of dying as a result of a living donor liver segment removal is between 0.2-2.0%. The risk of morbidity is anywhere between 1.3% (in highly experienced centers) to 60%. READ MORE Milk Thistle Milk Thistle is a resourceful natural plant which has many medicinal benefits. In herbal medication milk thistle is used in cases of liver diseases. READ MORE Pancreatitis Pancreatitis or inflammation of the pancreas may show up as acute pancreatitis or chronic pain. Alcohol consumption is the main offender. Treatment requires hospitalization and at times surgery. READ MORE Wilson's Disease This is a rare inherited systemic disorder of copper metabolism, affecting the liver mainly before other organs. READ MORE Most Popular on Medindia How to Reduce School Bag Weight - Simple Tips Pregnancy Confirmation Calculator Accident and Trauma Care More News on: Alcoholic Liver DiseaseHepatitis ALiverPancreatitisWilson's DiseaseMilk ThistleCurrent Treatments for Liver CancerFatty Liver Disease: A Growing Health Problem in IndiaLiving Donor Liver Transplant: What Are the Risks?